Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT00089167
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of primary systemic (AL) amyloidosis within the past 12 months
* High- or low-risk disease, determined by the extent of systemic organ involvement with disease and patient age
PATIENT CHARACTERISTICS:
Age
* 18 and over
Performance status
* SWOG 0-3
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Cardiovascular
* No New York Heart Association class III or IV congestive heart failure
* No restrictive cardiomyopathy requiring oxygen
* No myocardial infarction within the past 6 months
* No symptomatic cardiac arrhythmia within the past 60 days
Other
* No other active malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I cancer in complete remission
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No prior chemotherapy for AL amyloidosis
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Other
* No other prior or concurrent therapy for AL amyloidosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00089167
Study Brief:
Protocol Section:
NCT00089167